Health ❯ Healthcare

Research and Development

Clinical Trials Clinical Research Drug Development Innovative Therapies Pharmaceuticals Biotechnology Innovative Treatments Medical Innovations Clinical Evidence Gene Therapy

FDA Panel Rejects Deramiocel Cardiac Claim After Lancet Publishes HOPE‑3 Results

A 9–3 advisory vote and critical FDA reviews increase doubt about final approval ahead of the August 22 PDUFA date.

Pfizer’s Oral Drug Shows Strong Phase 3 Results in Nonsegmental Vitiligo

Spero Licenses Innovent’s Anti‑CD40L Antibody Outside Greater China in Up to $1.1 Billion Deal

Silo Pharma Raises $4 Million in Private Placement as Shares Fall 28%

Ipsen Says Dysport Met Phase 3 Endpoints for Episodic and Chronic Migraine

Duke Scientists Grow Retinal Blood-Vessel Cells From Human iPSCs

NICE Approves Teplizumab for Early Type 1 Diabetes on the NHS

NHS CAR‑T Puts Most Trial Lupus Patients Into Remission

King's College Hospital Opens UK's First Rooftop Critical Care Garden

Ipsen Says First Head-to-Head Trial Finds Dysport Matches Botox on Safety and Lasts Slightly Longer

Cormorant Takes $55 Million Stake in Dianthus After 350% Rally

FDA Seeks Public Input to Repurpose Approved Drugs for Hard-to-Treat Conditions

Home Blood Test and Online Checks Flag Alzheimer’s Risk in Small Study

NIMS, IISc and TANUH Begin Talks on AI Partnership for Patient Care

Moderna Beats Q1 Forecast as Overseas COVID Shot Sales Rebound

LEO Pharma to Acquire Replay in $50 Million Gene-Therapy Deal

FDA Grants Orphan Drug Status to Immutep’s Efti for Soft Tissue Sarcoma

Keytruda’s Price Faces New Scrutiny in Germany After Spending Tops €2 Billion

Germany to Cover Four Off-Label Drugs for Long Covid Under Statutory Insurance

Brazil Sets Deal to Produce Cancer Immunotherapy for the Public Health System